Live Trial updates

Live Trial news coverage of developments with the latest updates. Stay on top of latest Trial news stories and find out what just happened, what is going on with Trial. The latest real-time news updates and headlines on Trial
New Immunotherapy Doubles Survival in Advanced NSCLC
Early Brain Radiation Benefits EGFR-mutant NSCLC Patients
Mobile CT Expands Lung Screening for Brazil's Underserved
K-Beauty Arrives at Coles in Skincare Glow-Up
Fecal Transplant Promises Relief for Immunotherapy Colitis
Darwin Boosts Accessibility and Inclusivity
Cairns Hospital Expansion Gains Major Milestone
Georgetown Reveals PAPILLON Trial: Long-Term Lung Cancer Survival
MRI Brain Watch Beats Cranial Radiation in Lung Cancer
Azithromycin Use Rises, Infections Drop Post C-Section Trial
Building Evolutionary Traps for Viruses
UBC Study Reveals Early Decline in Huntington Patients
Cellular Senescence Trumps Mutations in Aging Evidence
Blind Retina Noise May Hinder Sight Restoration
Severt Joins Ashurst Perkins Coie's Antitrust Team
El Hishri Trial Set to Open May 4, 2027
Landmark Study Redefines Rare Disorders
IBAHRI Warns of Rising Settler Violence in Palestine
Employers Seek Resilient Staff, Risk Burnout
Research Probes Epilepsy Drug Safety With Anticoagulants
K-Beauty Hits Coles: Supermarket Skincare Glows Up
Magnetic Pulses Reprogram Immune Cells to Combat Cancer
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
Zidesamtinib Shows 93% Response in ROS1-positive NSCLC
Eight-Year ADAURA Update: Osimertinib Boosts Survival
Trastuzumab Deruxtecan Boosts Survival in HER2 Lung Cancer
Dr Tass Warns Peptide Enthusiasm Has Outpaced Evidence
Costly Phosphate? Homegrown Fertilizer Solution
$14M Partnership to Enhance Drought Resilience in Australia
Research Finds Low Overdiagnosis In Breast Cancer Screening
Clover Boost: Fortune for Dairy Farmers?
UQ Research: Creativity and Impact Highlighted
Hidden Rhythms Drive Heart Rate Dynamics
PBS Adds First Biologic for Uncontrolled COPD
MAVERICK Trial Backs Brain MRI Alone for Lung Cancer
Phase III TAISHAN-302: Tam-Peli Boosts Survival in SCLC
ARTEMIS-008: Risvutatug Boosts Survival in Lung Cancer
Ivonescimab Boosts Survival in PD-L1+ Advanced NSCLC
Sacituzumab, Pembrolizumab Combo Misses NSCLC Targets
Unions Urge New Govt: Workers Need Better Roadmap
Pumitamig Plus Elfetabart Shows Promise in Lung Cancer
Therapy Fails to Boost Survival After Dual Immunotherapy
Phase 1 Backs Phase 3 Dose for Lung Cancer Drug
Atezolizumab Combo Doubles Event-Free Survival in NSCLC
Subcutaneous Tarlatamab Safe, Effective in SCLC Trial
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
Building Better CAR T-Cells For Cancer Treatment